Greenovation develops next-generation therapeutics using its proprietary BryoTechnologyplatform. The company aims to optimize the production of highly-efficient glycoproteins for the treatment of diseases.

Greenovation is a privately-owned biopharmaceutical company based in Heilbronn, Germany. It was founded in 1999 by Prof. Dr. Ralf Reski and Prof. Dr. Gunter Neuhaus. Today, Greenovation Biotech GmbH is majority-owned by Zukunftsfonds Heilbronn and L EigenkapitalAgentur (Karlsruhe).